ETILX (ETILX) Stock Price & Analysis
ETILX (ETILX) fell 1.47% to USD 64.13 as of July 26, 2026 at 01:05 UTC, according to Nexqual real-time market data.
ETILX last closed at USD 65.09; the session ranged USD 64.13–64.13 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 50.93–69.94 (NAS). Source: Nexqual, July 26, 2026 at 01:05 UTC.
Key Statistics (as of July 26, 2026 at 01:05 UTC)
| Price | USD 64.13 |
|---|---|
| Change | ▼ 1.47% (down) |
| Previous Close | USD 65.09 |
| Open | USD 64.13 |
| Day Range | USD 64.13 – 64.13 |
| 52-Week Range | USD 50.93 – 69.94 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETILX)
Nexqual's technical model rates ETILX "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 01:05 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.35 (neutral) |
| vs SMA50 | Below (USD 65.35) |
| MACD | -0.13 (negative) |
Financial Health Score (ETILX)
Nexqual rates ETILX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 01:05 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETIHX | Eventide Healthcare & Life Scie | USD 55.69 | ▼ 0.52% |
| ETIDX | Eventide Dividend Opportunities | USD 22.19 | ▼ 0.67% |
| ETGLX | Eventide Gilead Fund | USD 61.43 | ▼ 2.12% |
| ETIMX | Eventide Multi-Asset Income Fun | USD 15.38 | ▼ 0.39% |
| ETIEX | Eventide Exponential Technologi | USD 16.84 | ▼ 3.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 01:05 UTC. This page is informational and not investment advice.